Close
ACHEMA MIDDLE EAST 2026

Twelve Digit National Drug Code Gets Proposed By The FDA

All labelling pertaining to the products that carry the national drug code will have to be updated if in case the FDA finalises its...

NICE Urged To Make The Kidney Cancer Treatment A Priority

NICE, the National Institute for Health and Care Excellence, has received a plea from the Kidney Cancer UK to bring about guidelines on the...

ABPI In UK Sees Possibility of Revenue Clawback Rate Rise

The Association of the British Pharmaceutical Industry (ABPI) has urged the government to take prompt action in response to the planned UK statutory revenue...

Pembrolizumab And Chemo-Boon To Endometrial Cancer Survival

A Phase III trial found that pembrolizumab plus chemotherapy enhanced survival in endometrial cancer patients. A Phase III clinical trial comparing pembrolizumab to chemotherapy (carboplatin...

Soon To Become A Reality- A Damaged Kidney Restoration

An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues in Germany, and the National Heart Centre Singapore (NHCS),...

A New Healer Antibody Medicine For Fatty Liver Disease

Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease. There is presently no treatment...

Clinical Trials Information System Now A Single Point Check

All initial clinical trial applications across the EU have to be submitted via the Clinical Trials Information System (CTIS) starting January 31, 2023. As per...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...